Not classified as an open-market trade.
Loading…
Reporting person on SEC Form 4
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
Disclosures on record
24
Companies involved
1
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Officer sold ~$2.92M of Boston Scientific
Scheduled in advanceOfficer sold ~$1.69M of Boston Scientific
Scheduled in advanceOfficer sold ~$363K of Boston Scientific
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.